Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00656_DB01201_nanopub.RAE-F5Ywq6stOWwNpXd4dKtXxUfj2vvEfYQKI82sbZsvY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00656_DB01201 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00656_DB01201 label "DDI between Trazodone and Rifapentine - The CYP3A4 inducer, Rifapentine, may decrease Trazodone efficacy by increasing Trazodone metabolism and clearance. Monitor for changes in Trazodone efficacy/toxicity if Rifapentine is initiated, discontinued or dose changed. [drugbank_resource:DB00656_DB01201]" assertion.
- drugbank_resource:DB00656_DB01201 identifier "drugbank_resource:DB00656_DB01201" assertion.
- drugbank_resource:DB00656_DB01201 title "DDI between Trazodone and Rifapentine - The CYP3A4 inducer, Rifapentine, may decrease Trazodone efficacy by increasing Trazodone metabolism and clearance. Monitor for changes in Trazodone efficacy/toxicity if Rifapentine is initiated, discontinued or dose changed." assertion.
- drugbank:DB01201 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB01201 assertion.
- drugbank:DB00656 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB01201 assertion.